Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: The POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 5004-5005

  Deharo, Pierre ^a,b,c   Pons, Coline ^a,b,c   Pankert, Mathieu ^a,b,c   Bonnet, Guillaume ^a,b,c   Quilici, Jacques ^a,b,c   Grosdidier, Charlotte ^a,b,c   Beguin, Shirley ^d   Morange, Pierre ^a,b,c   Alessi, Marie Christine ^a,b,c   Bonnet, Jean Louis ^a,b,c   Cuisset, Thomas ^a,b,c  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Acute coronary syndrome; Bleeding; Switch; Very low on treatment platelet reactivity (VLTPR)

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; ANTITHROMBOCYTIC AGENT; PIPERAZINE DERIVATIVE; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; LOADING DRUG DOSE; MALE; PLATELET REACTIVITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84886399928     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.121     Document Type: Article

References (8)

1. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo Variability in individual responsiveness to clopidogrel clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
2. P. Buonamici, R. Marcucci, and A. Migliorini Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2007 2312 2317
3. T. Cuisset, G. Cayla, and C. Frere Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment? EuroIntervention 5 2009 325 329
4. T. Cuisset, M. Loosveld, and P.E. Morange CYP2C19*2 and*17 alleles have a significant impact on platelet response and bleeding risk in patients treated with Prasugrel after acute coronary syndrome JACC Cardiovasc Interv 5 2012 1280 1287
5. T. Cuisset, C. Grosdidier, and A. Loundou Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (Predictor of Bleedings with Antiplatelet drugs) JACC Cardiovasc Interv 6 2013 854 863
6. M. Kerneis, J. Silvain, and J. Abtan Switching acute coronary syndrome patients from Prasugrel to Clopidogrel JACC Cardiovasc Interv 6 2013 158 165
7. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
8. P. Capranzano, C. Tamburino, and D. Capodanno Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on Clopidogrel therapy and effects of switching to Prasugrel 5 mg in patients with high platelet reactivity Thromb Haemost 106 2011 1149 1157